{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:55:58Z","timestamp":1780509358588,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T00:00:00Z","timestamp":1655596800000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19dm0207057"],"award-info":[{"award-number":["JP19dm0207057"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K08276"],"award-info":[{"award-number":["16K08276"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07123"],"award-info":[{"award-number":["19K07123"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.expneurol.2021.113791","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T10:44:01Z","timestamp":1624099441000},"page":"113791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Therapeutic potential of d-cysteine against in vitro and in vivo models of spinocerebellar ataxia"],"prefix":"10.1016","volume":"343","author":[{"given":"Tomoko","family":"Ohta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kurauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Hisatsune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Katsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2021.113791_bb0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0092-8674(94)90205-4","article-title":"Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice","volume":"79","author":"Alba","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2021.113791_bb0015","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1523\/JNEUROSCI.0876-14.2014","article-title":"Mutant-III spectrin causes mGluR1 mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5","volume":"34","author":"Armbrust","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0092-8674(95)90273-2","article-title":"SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat","volume":"82","author":"Burright","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2021.113791_bb0025","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12311-014-0605-0","article-title":"Decreased expression of glutamate transporter GLAST in Bergmann glia is associated with the loss of Purkinje neurons in the spinocerebellar ataxia type 1","volume":"14","author":"Cvetanovic","year":"2015","journal-title":"Cerebellum"},{"key":"10.1016\/j.expneurol.2021.113791_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuroscience.2015.01.003","article-title":"Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1","volume":"289","author":"Cvetanovic","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2021.113791_bb0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1099\/0022-1317-82-5-1013","article-title":"Analysis of the aphthovirus 2A\/2B polyprotein \u2018cleavage\u2019 mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal \u2018skip\u2019","volume":"82","author":"Donnelly","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-6273(01)00344-0","article-title":"The expression of vesicular glutamate transporters defines two classes of excitatory synapse","volume":"31","author":"Fremeau","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2021.113791_bb0050","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1523\/JNEUROSCI.3049-12.2012","article-title":"Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model","volume":"32","author":"Gan","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.116.238824","article-title":"Inhibition of leukotriene B 4 action mitigates intracerebral hemorrhage-associated pathological events in mice","volume":"360","author":"Hijioka","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2021.113791_bb0060","doi-asserted-by":"crossref","first-page":"14032","DOI":"10.1038\/mtm.2014.32","article-title":"Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model","volume":"1","author":"Huda","year":"2014","journal-title":"Mol. Ther. Meth. Clin. Dev."},{"key":"10.1016\/j.expneurol.2021.113791_bb0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fncel.2017.00292","article-title":"Motor and cerebellar architectural abnormalities during the early progression of Ataxia in a mouse model of SCA1 and how early prevention leads to a better outcome later in life","volume":"11","author":"Ibrahim","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1113\/jphysiol.2013.264309","article-title":"Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells","volume":"592","author":"Irie","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0075","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00415-016-8248-3","article-title":"Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia","volume":"263","author":"Ishibashi","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0080","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2016.10.026","article-title":"Vulnerability of Purkinje cells generated from spinocerebellar ataxia type 6 patient-derived iPSCs","volume":"17","author":"Ishida","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2021.113791_bb0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.12688\/f1000research.10485.1","article-title":"Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease","volume":"6","author":"Kano","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.expneurol.2021.113791_bb0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/ars.2010.3671","article-title":"Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson\u2019s disease","volume":"15","author":"Kida","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2021.113791_bb0095","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1096\/fj.12-226415","article-title":"Polysulfides are possible H 2 S-derived signaling molecules in rat brain","volume":"27","author":"Kimura","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2021.113791_bb0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.expneurol.2021.113791_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12311-013-0516-5","article-title":"Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells","volume":"13","author":"Konno","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.expneurol.2021.113791_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0896-6273(92)90164-9","article-title":"AMPA receptor subunits expressed by single purkinje cells","volume":"9","author":"Lambolez","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2021.113791_bb0115","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1073\/pnas.1617330114","article-title":"Glutamate transporter GLAST controls synaptic wrapping by Bergmann glia and ensures proper wiring of Purkinje cells","volume":"114","author":"Miyazaki","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1756-6606-6-48","article-title":"Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1","volume":"6","author":"Notartomaso","year":"2013","journal-title":"Mol. Brain"},{"key":"10.1016\/j.expneurol.2021.113791_bb0125","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00702-009-0289-7","article-title":"Potential pathophysiological role of d-amino acid oxidase in schizophrenia: Immunohistochemical and in situ hybridization study of the expression in human and rat brain","volume":"116","author":"Ono","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2021.113791_bb0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12974-017-0967-6","article-title":"Anti-inflammatory effects of astroglial \u03b17 nicotinic acetylcholine receptors are mediated by inhibition of the NF-\u039aB pathway and activation of the Nrf2 pathway","volume":"14","author":"Patel","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2021.113791_bb0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2007-971172","article-title":"Dominantly inherited ataxias: lessons learned from Machado-Joseph disease\/spinocerebellar ataxia type 3","volume":"27","author":"Paulson","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0140","doi-asserted-by":"crossref","first-page":"16125","DOI":"10.1038\/nmicrobiol.2016.125","article-title":"Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota","volume":"1","author":"Sasabe","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/nan.12649","article-title":"Ataxic phenotype and neurodegeneration are triggered by the impairment of chaperone-mediated autophagy in cerebellar neurons","volume":"47","author":"Sato","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nbd.2008.10.013","article-title":"Mutant \u03b3PKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells","volume":"33","author":"Seki","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2021.113791_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nbd.2018.08.022","article-title":"Lysosomal dysfunction and early glial activation are involved in the pathogenesis of spinocerebellar ataxia type 21 caused by mutant transmembrane protein 240","volume":"120","author":"Seki","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2021.113791_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mcn.2018.10.002","article-title":"d-Cysteine promotes dendritic development in primary cultured cerebellar Purkinje cells via hydrogen sulfide production","volume":"93","author":"Seki","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0165","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","article-title":"Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3","volume":"31","author":"Shakkottai","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2021.113791_bb0170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1293\/tox.2017-0002","article-title":"Comparisons of L-cysteine and D-cysteine toxicity in 4-week repeated-dose toxicity studies of rats receiving daily oral administration","volume":"30","author":"Shibui","year":"2017","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0175","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/ncomms2371","article-title":"A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells","volume":"4","author":"Shibuya","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2021.113791_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1113\/JP272950","article-title":"Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice","volume":"595","author":"Shuvaev","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cge.12808","article-title":"Spinocerebellar ataxia: relationship between phenotype and genotype \u2013 a review","volume":"90","author":"Sun","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.expneurol.2021.113791_bb0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1097-4547(19971101)50:3<433::AID-JNR9>3.0.CO;2-J","article-title":"Distribution of metabotropic glutamate receptor type 1a in Purkinje cell dendritic spines is independent of the presence of presynaptic parallel fibers","volume":"50","author":"Tak\u00e1cs","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2021.113791_bb0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nbd.2018.10.014","article-title":"Pharmacological enhancement of retinoid-related orphan receptor \u03b1 function mitigates spinocerebellar ataxia type 3 pathology","volume":"121","author":"Watanave","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2021.113791_bb0200","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/WNR.0000000000000969","article-title":"Aspirin suppresses neuronal apoptosis, reduces tissue inflammation, and restrains astrocyte activation by activating the Nrf2\/HO-1 signaling pathway","volume":"29","author":"Wei","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2021.113791_bb0205","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00204-018-2208-x","article-title":"Activation of autophagic flux and the Nrf2\/ARE signaling pathway by hydrogen sulfide protects against acrylonitrile-induced neurotoxicity in primary rat astrocytes","volume":"92","author":"Yang","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.expneurol.2021.113791_bb0210","first-page":"1","article-title":"Brain 3-mercaptopyruvate sulfurtransferase (3MST): cellular localization and downregulation after acute stroke","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2021.113791_bb0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12974-017-0940-4","article-title":"Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral haemorrhage in rats","volume":"14","author":"Zhao","year":"2017","journal-title":"J. Neuroinflammation"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621001990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488621001990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:53:00Z","timestamp":1762149180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488621001990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":43,"alternative-id":["S0014488621001990"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113791","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of d-cysteine against in vitro and in vivo models of spinocerebellar ataxia","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2021.113791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113791"}}